neurontin

Generic: gabapentin

Labeler: parke-davis div of pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name neurontin
Generic Name gabapentin
Labeler parke-davis div of pfizer inc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

gabapentin 600 mg/1

Manufacturer
Parke-Davis Div of Pfizer Inc

Identifiers & Regulatory

Product NDC 0071-0513
Product ID 0071-0513_07bff022-5505-4611-a9a0-ce5255c339ad
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020882
Marketing Start 1998-10-09
Marketing End 2026-06-30

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00710513
Hyphenated Format 0071-0513

Supplemental Identifiers

RxCUI
105028 105029 105030 261280 261281 283523 310430 310431 310432 310433 310434 351973
UPC
0300710513242
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name neurontin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number NDA020882 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 600 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (0071-0513-24)
source: ndc

Packages (1)

0071-0513-24 100 TABLET, FILM COATED in 1 BOTTLE (0071-0513-24)

Ingredients (1)

gabapentin (600 mg/1)

Linked Drug Pages (1)

Neurontin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "07bff022-5505-4611-a9a0-ce5255c339ad", "openfda": {"nui": ["N0000008486"], "upc": ["0300710513242"], "unii": ["6CW7F3G59X"], "rxcui": ["105028", "105029", "105030", "261280", "261281", "283523", "310430", "310431", "310432", "310433", "310434", "351973"], "spl_set_id": ["ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (0071-0513-24)", "package_ndc": "0071-0513-24", "marketing_end_date": "20260630", "marketing_start_date": "19981009"}], "brand_name": "Neurontin", "product_id": "0071-0513_07bff022-5505-4611-a9a0-ce5255c339ad", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0071-0513", "generic_name": "gabapentin", "labeler_name": "Parke-Davis Div of Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neurontin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "600 mg/1"}], "application_number": "NDA020882", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "19981009"}